These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32342945)

  • 21. Successful bortezomib/dexamethasone induction therapy with lenalidomide in an elderly patient with primary plasma cell leukemia complicated by renal failure and pulmonary hypertension.
    Tamura S; Koyama A; Shiotani C; Kurihara T; Nishikawa A; Okamoto Y; Fujimoto T
    Intern Med; 2014; 53(11):1171-5. PubMed ID: 24881743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
    Royer B; Minvielle S; Diouf M; Roussel M; Karlin L; Hulin C; Arnulf B; Macro M; Cailleres S; Brion A; Brechignac S; Belhadj K; Chretien ML; Wetterwald M; Chaleteix C; Tiab M; Leleu X; Frenzel L; Garderet L; Choquet S; Fuzibet JG; Dauriac C; Forneker LM; Benboubker L; Facon T; Moreau P; Avet-Loiseau H; Marolleau JP
    J Clin Oncol; 2016 Jun; 34(18):2125-32. PubMed ID: 27114594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary plasma cell leukaemia: a report of 18 cases.
    Costello R; Sainty D; Bouabdallah R; Fermand JP; Delmer A; Diviné M; Marolleau JP; Gastaut JA; Olive D; Rousselot P; Chaïbi P
    Leuk Res; 2001 Feb; 25(2):103-7. PubMed ID: 11166824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary plasma cell leukemia with extensive dense osteosclerosis: complete remission following combination chemotherapy.
    Kuo MC; Shih LY
    Ann Hematol; 1995 Sep; 71(3):147-51. PubMed ID: 7548334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cauda equina relapse after autologous stem cell transplantation in a patient with primary plasma cell leukemia].
    Okudaira T; Nagasaki A; Miyagi T; Yoshida M; Tamaki K; Takasu N
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):743-6. PubMed ID: 20414040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic capillary leak syndrome preceding plasma cell leukaemia.
    Ghosh K; Madkaikar M; Iyer Y; Pathare A; Jijina F; Mohanty D
    Acta Haematol; 2001; 106(3):118-21. PubMed ID: 11713377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Plasma Cell Leukemia Associated with t(6;14)(p21;q32) and IGH Rearrangement: A Case Study and Review of the Literature.
    Cho SY; Lim G; Oh SH; Lee HJ; Suh JT; Lee J; Lee WI; Lee HG; Yoon HJ; Park TS
    Ann Clin Lab Sci; 2011; 41(3):277-81. PubMed ID: 22075513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment.
    Brück P; Mousset S; Bühme A; Hoelzer D; Atta J
    Int J Hematol; 2007 Jul; 86(1):66-8. PubMed ID: 17675269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
    García-Sanz R; Orfão A; González M; Tabernero MD; Bladé J; Moro MJ; Fernández-Calvo J; Sanz MA; Pérez-Simón JA; Rasillo A; Miguel JF
    Blood; 1999 Feb; 93(3):1032-7. PubMed ID: 9920853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary plasma cell leukemia occuring in the young.
    Raj RS; Najeeb S; Aruna R; Pavithran K; Thomas M
    Indian J Cancer; 2003; 40(3):116-7. PubMed ID: 14716116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary plasma cell leukaemia in a 39-year-old man.
    Kasinathan G
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32709663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party.
    D'Arena G; Valentini CG; Pietrantuono G; Guariglia R; Martorelli MC; Mansueto G; Villani O; Onofrillo D; Falcone A; Specchia G; Semenzato G; Di Renzo N; Mastrullo L; Venditti A; Ferrara F; Palumbo A; Pagano L; Musto P
    Ann Oncol; 2012 Jun; 23(6):1499-502. PubMed ID: 22039089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia.
    Gozzetti A; Musto P; Defina M; D'Auria F; Papini G; Statuto T; D'Arena G; Bocchia M
    Br J Haematol; 2012 May; 157(4):497-8. PubMed ID: 22296516
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.
    Tanaka K; Toyota S; Akiyama M; Wakimoto N; Nakamura Y; Najima Y; Doki N; Kakihana K; Igarashi A; Kobayashi T; Ohashi K; Kudo D; Shinagawa A; Takano H; Fujio T; Okoshi Y; Hori M; Kumagai T; Saito T; Mukae J; Yamamoto K; Tsutsumi I; Komeno T; Yoshida C; Yamamoto M; Kojima H;
    Acta Haematol; 2019; 141(2):111-118. PubMed ID: 30726834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary plasma cell leukaemia. A case report and a review of the literature.
    Osanto S; Müller HP; Schuit HR; Van Nieuwkoop JA; Willemze R
    Acta Haematol; 1983; 70(2):122-9. PubMed ID: 6408874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone formation following lenalidomide-dexamethasone combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood stem cell transplantation: report of a case and review of the literature.
    Sekiguchi Y; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2015; 8(8):9609-19. PubMed ID: 26464727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal evolution at leukemic relapse of multiple myeloma (secondary plasma cell leukemia) responding to re-treatment with bortezomib-based therapy. A case record.
    Bernardeschi P; Pirrotta MT; Montenora I; Giustarini G; Ferreri MI; Simi P; Fiorentini G
    Leuk Res; 2010 Apr; 34(4):e104-5. PubMed ID: 19889456
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma cell leukemia in a 34-year-old male: rare scenario case report.
    Issa M; Hannouneh ZA; Alabbas Z; Hussein F; Issa R
    Ann Med Surg (Lond); 2023 Nov; 85(11):5686-5689. PubMed ID: 37915713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of allogeneic hematopoietic stem cell transplantation for primary plasma cell leukemia after treatment with daratumumab.
    Horisawa Y; Kondo T; Hishizawa M; Yamashita K; Takaori-Kondo A
    Ann Hematol; 2020 Nov; 99(11):2699-2701. PubMed ID: 32318778
    [No Abstract]   [Full Text] [Related]  

  • 40. Patterns of relapse or progression after bortezomib-based salvage therapy in patients with relapsed/refractory multiple myeloma.
    Ahn JS; Jung SH; Yang DH; Bae SY; Kim YK; Kim HJ; Lee JJ
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):389-94. PubMed ID: 24630919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.